Rob H.A. Verhoeven
Dutch Cancer Society(NL)Amsterdam Neuroscience(NL)Amsterdam University of the Arts(NL)Netherlands Comprehensive Cancer Organisation(NL)Amsterdam University Medical Centers(NL)Amsterdam University Medical Centers(NL)Cancer Center AmsterdamCancer Center Amsterdam(NL)University of Amsterdam(NL)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Esophageal and GI Pathology, Colorectal Cancer Screening and Detection, Metastasis and carcinoma case studies
Most-Cited Works
- → Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands(2020)713 cited
- → The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study(2022)693 cited
- → Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes(2007)471 cited
- → Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993(2013)326 cited
- → An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients(2018)302 cited
- → Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)(2021)